BNP Paribas Financial Markets’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-36,763
| Closed | -$3.42M | – | 4427 |
|
|
2021
Q4 | $3.42M | Buy |
36,763
+21,687
| +144% | +$1.43M | ﹤0.01% | 1622 |
|
|
2021
Q3 | $898K | Buy |
15,076
+9,088
| +152% | +$537K | ﹤0.01% | 2442 |
|
|
2021
Q2 | $408K | Sell |
5,988
-16,942
| -74% | -$1.1M | ﹤0.01% | 2619 |
|
|
2021
Q1 | $1.59M | Buy |
22,930
+14,222
| +163% | +$1.09M | ﹤0.01% | 1831 |
|
|
2020
Q4 | $669K | Sell |
8,708
-5,056
| -37% | -$379K | ﹤0.01% | 2300 |
|
|
2020
Q3 | $1.03M | Buy |
13,764
+3,590
| +35% | +$239K | ﹤0.01% | 1794 |
|
|
2020
Q2 | $640K | Sell |
10,174
-19,810
| -66% | -$1.09M | ﹤0.01% | 1993 |
|
|
2020
Q1 | $1.26M | Buy |
29,984
+16,349
| +120% | +$750K | ﹤0.01% | 1761 |
|
|
2019
Q4 | $619K | Sell |
13,635
-2,201
| -14% | -$104K | ﹤0.01% | 2315 |
|
|
2019
Q3 | $725K | Buy |
15,836
+9,219
| +139% | +$518K | ﹤0.01% | 2021 |
|
|
2019
Q2 | $388K | Sell |
6,617
-4,856
| -42% | -$251K | ﹤0.01% | 2157 |
|
|
2019
Q1 | $514K | Buy |
11,473
+10,342
| +914% | +$474K | ﹤0.01% | 2083 |
|
|
2018
Q4 | $44.1K | Sell |
1,131
-1,691
| -60% | -$66.4K | ﹤0.01% | 2780 |
|
|
2018
Q3 | $130K | Buy |
2,822
+235
| +9% | +$9.53K | ﹤0.01% | 2610 |
|
|
2018
Q2 | $113K | Sell |
2,587
-6,051
| -70% | -$260K | ﹤0.01% | 2733 |
|
|
2018
Q1 | $341K | Buy |
8,638
+308
| +4% | +$12K | ﹤0.01% | 2461 |
|
|
2017
Q4 | $283K | Buy |
8,330
+3,951
| +90% | +$113K | ﹤0.01% | 2780 |
|
|
2017
Q3 | $112K | Buy |
4,379
+430
| +11% | +$9.86K | ﹤0.01% | 2716 |
|
|
2017
Q2 | $66.6K | Buy |
3,949
+3,449
| +690% | +$47.3K | ﹤0.01% | 3037 |
|
|
2017
Q1 | $7.29K | Sell |
500
-1,257
| -72% | -$18.6K | ﹤0.01% | 3228 |
|
|
2016
Q4 | $24.9K | Sell |
1,757
-263
| -13% | -$4.07K | ﹤0.01% | 3097 |
|
|
2016
Q3 | $35.3K | Buy |
2,020
+1,071
| +113% | +$17.8K | ﹤0.01% | 2593 |
|
|
2016
Q2 | $16.2K | Buy |
+949
| New | +$17K | ﹤0.01% | 2679 |
|
|
2016
Q1 | – | Sell |
-5,234
| Closed | -$99.5K | – | 3224 |
|
|
2015
Q4 | $99.5K | Buy |
5,234
+228
| +5% | +$4.65K | ﹤0.01% | 2333 |
|
|
2015
Q3 | $95.6K | Sell |
5,006
-908
| -15% | -$30.8K | ﹤0.01% | 2423 |
|
|
2015
Q2 | $274K | Buy |
5,914
+5,432
| +1,127% | +$236K | ﹤0.01% | 1575 |
|
|
2015
Q1 | $21.1K | Buy |
+482
| New | +$22.4K | ﹤0.01% | 2345 |
|
|
2014
Q4 | – | Sell |
-1,296
| Closed | -$54.3K | – | 3458 |
|
|
2014
Q3 | $54.3K | Buy |
1,296
+1,245
| +2,441% | +$55.6K | ﹤0.01% | 2543 |
|
|
2014
Q2 | $3K | Buy |
+51
| New | +$3.21K | ﹤0.01% | 2863 |
|
|
2013
Q4 | – | Sell |
-5,441
| Closed | -$287K | – | 4156 |
|
|
2013
Q3 | $287K | Sell |
5,441
-2,558
| -32% | -$172K | ﹤0.01% | 1965 |
|
|
2013
Q2 | $616K | Buy |
+7,999
| New | +$653K | ﹤0.01% | 1363 |
|
BNP Paribas Financial Markets's ARNA Position: Q1 2022 in Review
BNP Paribas Financial Markets sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 36,763 shares — an estimated $3.42M sold.
BNP Paribas Financial Markets first reported a position in ARNA in Q2 2013 and held it in 31 quarters. The position peaked at $3.42M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- BNP Paribas Financial Markets reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 36,763 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.42M.
- BNP Paribas Financial Markets first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 31 quarters.
- BNP Paribas Financial Markets's Arena Pharmaceuticals Inc position peaked at $3.42M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.